论文部分内容阅读
虽然糖尿病肾病在我国的患病率正在逐渐增多,但是非糖尿病慢性肾小球疾病仍是目前我国终末期肾病的最主要的病因[1]。延缓慢性肾小球疾病向终末期肾病进展除了必要的免疫抑制治疗以外,针对非免疫发病机制的的治疗同样十分重要。血管紧张素转换酶抑制剂(angiotensin-converting-
Although the prevalence of diabetic nephropathy in China is gradually increasing, but non-diabetic chronic glomerular disease is still the most important cause of end-stage renal disease in China [1]. Delaying the progression of chronic glomerular disease to end-stage renal disease In addition to the necessary immunosuppressive therapy, therapies for non-immune pathogenesis are equally important. Angiotensin-converting-